News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

pSivida Corp (PSDV) Takes Another Stab at FDA Approval for Iluvien


3/27/2013 8:26:58 AM

As pSivida gears up to begin distribution of its Illuvien eye treatment in Europe, it plans to re-submit its new drug application to the FDA for the drug/device combination. It's been a rocky road for pSivida's (NSDQ:PSDV) Illuvien, a drug/device combination for macular degeneration, but the company hopes that new trial data will pave the way to regulatory approval in the U.S.

Read at MassDevice

comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES